Myrobalan-Mediated Nanocolloids in Controlling Marine Pathogens
Aquaculture production is affected by disease outbreak, which affects the production, profitability, and sustainability of the global aquaculture industry. Antibiotics have been widely used to control various infectious diseases. Indiscriminate usage of antibiotics results in development of antibiot...
Gespeichert in:
| Veröffentlicht in: | Applied biochemistry and biotechnology 2022-03, Vol.194 (3), p.1120-1135 |
|---|---|
| Hauptverfasser: | , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 1135 |
|---|---|
| container_issue | 3 |
| container_start_page | 1120 |
| container_title | Applied biochemistry and biotechnology |
| container_volume | 194 |
| creator | Ranjani, S. Parthasarathy, Pradeep Rameshkumar, P. Hemalatha, S. |
| description | Aquaculture production is affected by disease outbreak, which affects the production, profitability, and sustainability of the global aquaculture industry. Antibiotics have been widely used to control various infectious diseases. Indiscriminate usage of antibiotics results in development of antibiotic resistance in pathogens. This current study aims to synthesize myrobalan-mediated green silver nanocolloids (MBNc) by using the extract of three myrobalans and characterized by using various physiochemical techniques. Antibacterial potential of MBNc was screened in vibriosis causing pathogens (
V. harveyi
,
V. alginolyticus
,
V. Parahaemolyticus
), and foodborne pathogen
S. haemolyticus
, isolated from infected fish. Further, the presence of ESBL genes including CTX-M-15 and Amp C was analyzed in control and MBNc-treated strains. From our studies, it was observed that MBNc was very effective in controlling the growth. MBNc confirmed the anti-biofilm property in all tested marine pathogens and effectively abolish the genes encoding CTX-M-15 in tested pathogens. Thus, MBNc can be formulated to control the growth of marine pathogens and it can be used as an alternative to antibiotics to prevent infection in cage culturing and aquafarming. |
| doi_str_mv | 10.1007/s12010-022-03816-9 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2620785975</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2628014585</sourcerecordid><originalsourceid>FETCH-LOGICAL-c375t-160b1fed0d59042d0897c395da041a5b5c5f957cc534120adfd92272795a7c683</originalsourceid><addsrcrecordid>eNp9kE1PAyEQhonR2Fr9Ax7MJl68rA6wLMvJmMavpFUPeiYssHWbLVTYHvrvpbZq4sETGXjmZeZB6BTDJQbgVxETwJADITnQCpe52ENDzJhIVwLvoyEQTnNCKjFARzHOATCpGD9EA8qAclzyIbqeroOvVadcPrWmVb012ZNyXvuu862JWeuysXd9SHXrZtlUhdbZ7EX1735mXTxGB43qoj3ZnSP0dnf7On7IJ8_3j-ObSa4pZ32OS6hxYw0YJqAgBirBNRXMKCiwYjXTrBGMa81okbZSpjGCEE64YIrrsqIjdLHNXQb_sbKxl4s2atulwa1fRUlKArxigrOEnv9B534VXJpuQ1WAC1ZtKLKldPAxBtvIZWgXKqwlBrnRK7d6ZdIrv_RKkZrOdtGremHNT8u3zwTQLRDTk5vZ8Pv3P7Gf2aqDVg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2628014585</pqid></control><display><type>article</type><title>Myrobalan-Mediated Nanocolloids in Controlling Marine Pathogens</title><source>MEDLINE</source><source>SpringerNature Journals</source><creator>Ranjani, S. ; Parthasarathy, Pradeep ; Rameshkumar, P. ; Hemalatha, S.</creator><creatorcontrib>Ranjani, S. ; Parthasarathy, Pradeep ; Rameshkumar, P. ; Hemalatha, S.</creatorcontrib><description>Aquaculture production is affected by disease outbreak, which affects the production, profitability, and sustainability of the global aquaculture industry. Antibiotics have been widely used to control various infectious diseases. Indiscriminate usage of antibiotics results in development of antibiotic resistance in pathogens. This current study aims to synthesize myrobalan-mediated green silver nanocolloids (MBNc) by using the extract of three myrobalans and characterized by using various physiochemical techniques. Antibacterial potential of MBNc was screened in vibriosis causing pathogens (
V. harveyi
,
V. alginolyticus
,
V. Parahaemolyticus
), and foodborne pathogen
S. haemolyticus
, isolated from infected fish. Further, the presence of ESBL genes including CTX-M-15 and Amp C was analyzed in control and MBNc-treated strains. From our studies, it was observed that MBNc was very effective in controlling the growth. MBNc confirmed the anti-biofilm property in all tested marine pathogens and effectively abolish the genes encoding CTX-M-15 in tested pathogens. Thus, MBNc can be formulated to control the growth of marine pathogens and it can be used as an alternative to antibiotics to prevent infection in cage culturing and aquafarming.</description><identifier>ISSN: 0273-2289</identifier><identifier>ISSN: 1559-0291</identifier><identifier>EISSN: 1559-0291</identifier><identifier>DOI: 10.1007/s12010-022-03816-9</identifier><identifier>PMID: 35037167</identifier><language>eng</language><publisher>New York: Springer US</publisher><subject>Animals ; Anti-Bacterial Agents - chemistry ; Anti-Bacterial Agents - pharmacology ; Antibiotic resistance ; Antibiotics ; Antiinfectives and antibacterials ; Aquaculture ; Aquaculture products ; Biochemistry ; Biofilms ; Biofilms - drug effects ; Biofilms - growth & development ; Biotechnology ; Chemistry ; Chemistry and Materials Science ; Colloids - chemistry ; Economics ; Foodborne pathogens ; Genes ; Infectious diseases ; Metal Nanoparticles - chemistry ; Original Article ; Pathogens ; Physiochemistry ; Profitability ; Silver - chemistry ; Silver - pharmacology ; Vibrio - drug effects ; Vibriosis</subject><ispartof>Applied biochemistry and biotechnology, 2022-03, Vol.194 (3), p.1120-1135</ispartof><rights>The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature 2022</rights><rights>2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.</rights><rights>The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature 2022.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c375t-160b1fed0d59042d0897c395da041a5b5c5f957cc534120adfd92272795a7c683</citedby><cites>FETCH-LOGICAL-c375t-160b1fed0d59042d0897c395da041a5b5c5f957cc534120adfd92272795a7c683</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s12010-022-03816-9$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s12010-022-03816-9$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>314,780,784,27924,27925,41488,42557,51319</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/35037167$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Ranjani, S.</creatorcontrib><creatorcontrib>Parthasarathy, Pradeep</creatorcontrib><creatorcontrib>Rameshkumar, P.</creatorcontrib><creatorcontrib>Hemalatha, S.</creatorcontrib><title>Myrobalan-Mediated Nanocolloids in Controlling Marine Pathogens</title><title>Applied biochemistry and biotechnology</title><addtitle>Appl Biochem Biotechnol</addtitle><addtitle>Appl Biochem Biotechnol</addtitle><description>Aquaculture production is affected by disease outbreak, which affects the production, profitability, and sustainability of the global aquaculture industry. Antibiotics have been widely used to control various infectious diseases. Indiscriminate usage of antibiotics results in development of antibiotic resistance in pathogens. This current study aims to synthesize myrobalan-mediated green silver nanocolloids (MBNc) by using the extract of three myrobalans and characterized by using various physiochemical techniques. Antibacterial potential of MBNc was screened in vibriosis causing pathogens (
V. harveyi
,
V. alginolyticus
,
V. Parahaemolyticus
), and foodborne pathogen
S. haemolyticus
, isolated from infected fish. Further, the presence of ESBL genes including CTX-M-15 and Amp C was analyzed in control and MBNc-treated strains. From our studies, it was observed that MBNc was very effective in controlling the growth. MBNc confirmed the anti-biofilm property in all tested marine pathogens and effectively abolish the genes encoding CTX-M-15 in tested pathogens. Thus, MBNc can be formulated to control the growth of marine pathogens and it can be used as an alternative to antibiotics to prevent infection in cage culturing and aquafarming.</description><subject>Animals</subject><subject>Anti-Bacterial Agents - chemistry</subject><subject>Anti-Bacterial Agents - pharmacology</subject><subject>Antibiotic resistance</subject><subject>Antibiotics</subject><subject>Antiinfectives and antibacterials</subject><subject>Aquaculture</subject><subject>Aquaculture products</subject><subject>Biochemistry</subject><subject>Biofilms</subject><subject>Biofilms - drug effects</subject><subject>Biofilms - growth & development</subject><subject>Biotechnology</subject><subject>Chemistry</subject><subject>Chemistry and Materials Science</subject><subject>Colloids - chemistry</subject><subject>Economics</subject><subject>Foodborne pathogens</subject><subject>Genes</subject><subject>Infectious diseases</subject><subject>Metal Nanoparticles - chemistry</subject><subject>Original Article</subject><subject>Pathogens</subject><subject>Physiochemistry</subject><subject>Profitability</subject><subject>Silver - chemistry</subject><subject>Silver - pharmacology</subject><subject>Vibrio - drug effects</subject><subject>Vibriosis</subject><issn>0273-2289</issn><issn>1559-0291</issn><issn>1559-0291</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><recordid>eNp9kE1PAyEQhonR2Fr9Ax7MJl68rA6wLMvJmMavpFUPeiYssHWbLVTYHvrvpbZq4sETGXjmZeZB6BTDJQbgVxETwJADITnQCpe52ENDzJhIVwLvoyEQTnNCKjFARzHOATCpGD9EA8qAclzyIbqeroOvVadcPrWmVb012ZNyXvuu862JWeuysXd9SHXrZtlUhdbZ7EX1735mXTxGB43qoj3ZnSP0dnf7On7IJ8_3j-ObSa4pZ32OS6hxYw0YJqAgBirBNRXMKCiwYjXTrBGMa81okbZSpjGCEE64YIrrsqIjdLHNXQb_sbKxl4s2atulwa1fRUlKArxigrOEnv9B534VXJpuQ1WAC1ZtKLKldPAxBtvIZWgXKqwlBrnRK7d6ZdIrv_RKkZrOdtGremHNT8u3zwTQLRDTk5vZ8Pv3P7Gf2aqDVg</recordid><startdate>20220301</startdate><enddate>20220301</enddate><creator>Ranjani, S.</creator><creator>Parthasarathy, Pradeep</creator><creator>Rameshkumar, P.</creator><creator>Hemalatha, S.</creator><general>Springer US</general><general>Springer Nature B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7ST</scope><scope>7T7</scope><scope>7TM</scope><scope>7X7</scope><scope>7XB</scope><scope>88A</scope><scope>88E</scope><scope>88I</scope><scope>8AO</scope><scope>8FD</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M2P</scope><scope>M7P</scope><scope>P64</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>Q9U</scope><scope>RC3</scope><scope>SOI</scope><scope>7X8</scope></search><sort><creationdate>20220301</creationdate><title>Myrobalan-Mediated Nanocolloids in Controlling Marine Pathogens</title><author>Ranjani, S. ; Parthasarathy, Pradeep ; Rameshkumar, P. ; Hemalatha, S.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c375t-160b1fed0d59042d0897c395da041a5b5c5f957cc534120adfd92272795a7c683</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Animals</topic><topic>Anti-Bacterial Agents - chemistry</topic><topic>Anti-Bacterial Agents - pharmacology</topic><topic>Antibiotic resistance</topic><topic>Antibiotics</topic><topic>Antiinfectives and antibacterials</topic><topic>Aquaculture</topic><topic>Aquaculture products</topic><topic>Biochemistry</topic><topic>Biofilms</topic><topic>Biofilms - drug effects</topic><topic>Biofilms - growth & development</topic><topic>Biotechnology</topic><topic>Chemistry</topic><topic>Chemistry and Materials Science</topic><topic>Colloids - chemistry</topic><topic>Economics</topic><topic>Foodborne pathogens</topic><topic>Genes</topic><topic>Infectious diseases</topic><topic>Metal Nanoparticles - chemistry</topic><topic>Original Article</topic><topic>Pathogens</topic><topic>Physiochemistry</topic><topic>Profitability</topic><topic>Silver - chemistry</topic><topic>Silver - pharmacology</topic><topic>Vibrio - drug effects</topic><topic>Vibriosis</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ranjani, S.</creatorcontrib><creatorcontrib>Parthasarathy, Pradeep</creatorcontrib><creatorcontrib>Rameshkumar, P.</creatorcontrib><creatorcontrib>Hemalatha, S.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Environment Abstracts</collection><collection>Industrial and Applied Microbiology Abstracts (Microbiology A)</collection><collection>Nucleic Acids Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Biology Database (Alumni Edition)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Science Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Science Database</collection><collection>Biological Science Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central Basic</collection><collection>Genetics Abstracts</collection><collection>Environment Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Applied biochemistry and biotechnology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ranjani, S.</au><au>Parthasarathy, Pradeep</au><au>Rameshkumar, P.</au><au>Hemalatha, S.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Myrobalan-Mediated Nanocolloids in Controlling Marine Pathogens</atitle><jtitle>Applied biochemistry and biotechnology</jtitle><stitle>Appl Biochem Biotechnol</stitle><addtitle>Appl Biochem Biotechnol</addtitle><date>2022-03-01</date><risdate>2022</risdate><volume>194</volume><issue>3</issue><spage>1120</spage><epage>1135</epage><pages>1120-1135</pages><issn>0273-2289</issn><issn>1559-0291</issn><eissn>1559-0291</eissn><abstract>Aquaculture production is affected by disease outbreak, which affects the production, profitability, and sustainability of the global aquaculture industry. Antibiotics have been widely used to control various infectious diseases. Indiscriminate usage of antibiotics results in development of antibiotic resistance in pathogens. This current study aims to synthesize myrobalan-mediated green silver nanocolloids (MBNc) by using the extract of three myrobalans and characterized by using various physiochemical techniques. Antibacterial potential of MBNc was screened in vibriosis causing pathogens (
V. harveyi
,
V. alginolyticus
,
V. Parahaemolyticus
), and foodborne pathogen
S. haemolyticus
, isolated from infected fish. Further, the presence of ESBL genes including CTX-M-15 and Amp C was analyzed in control and MBNc-treated strains. From our studies, it was observed that MBNc was very effective in controlling the growth. MBNc confirmed the anti-biofilm property in all tested marine pathogens and effectively abolish the genes encoding CTX-M-15 in tested pathogens. Thus, MBNc can be formulated to control the growth of marine pathogens and it can be used as an alternative to antibiotics to prevent infection in cage culturing and aquafarming.</abstract><cop>New York</cop><pub>Springer US</pub><pmid>35037167</pmid><doi>10.1007/s12010-022-03816-9</doi><tpages>16</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0273-2289 |
| ispartof | Applied biochemistry and biotechnology, 2022-03, Vol.194 (3), p.1120-1135 |
| issn | 0273-2289 1559-0291 1559-0291 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_2620785975 |
| source | MEDLINE; SpringerNature Journals |
| subjects | Animals Anti-Bacterial Agents - chemistry Anti-Bacterial Agents - pharmacology Antibiotic resistance Antibiotics Antiinfectives and antibacterials Aquaculture Aquaculture products Biochemistry Biofilms Biofilms - drug effects Biofilms - growth & development Biotechnology Chemistry Chemistry and Materials Science Colloids - chemistry Economics Foodborne pathogens Genes Infectious diseases Metal Nanoparticles - chemistry Original Article Pathogens Physiochemistry Profitability Silver - chemistry Silver - pharmacology Vibrio - drug effects Vibriosis |
| title | Myrobalan-Mediated Nanocolloids in Controlling Marine Pathogens |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-19T08%3A23%3A05IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Myrobalan-Mediated%20Nanocolloids%20in%20Controlling%20Marine%20Pathogens&rft.jtitle=Applied%20biochemistry%20and%20biotechnology&rft.au=Ranjani,%20S.&rft.date=2022-03-01&rft.volume=194&rft.issue=3&rft.spage=1120&rft.epage=1135&rft.pages=1120-1135&rft.issn=0273-2289&rft.eissn=1559-0291&rft_id=info:doi/10.1007/s12010-022-03816-9&rft_dat=%3Cproquest_cross%3E2628014585%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2628014585&rft_id=info:pmid/35037167&rfr_iscdi=true |